Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy

Researchers performed a bioinformatic analysis of adenosine-to-inosine (A-to-I) RNA editing in human melanoma samples and determined that pre-therapy levels of A-to-I RNA editing negatively correlate with survival times.